Dr Yasir Khan

MBBS, FRACP
Medical Oncologist
Make an Appointment

Dr Yasir Khan is a strong advocate for clinical trials and local research, ensuring his patients have access to the latest treatment options close to home. He brings a holistic, evidence-based approach to his practice and his patients benefit from his clinical research background and deep understanding of cancer care.

Biography

Dr Yasir Khan is a medical oncologist at Icon Cancer Centre Rockingham. In 2008 he completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at the University of Health & Sciences in Lahore, Pakistan before relocating to Western Australia. Dr Khan subsequently commenced specialist oncology training at Sir Charles Gairdner Hospital and Fiona Stanley Hospital. In 2020 he completed a one-year clinical research fellowship in melanoma and kidney cancers at the Royal Marsden Hospital in London. During his fellowship Dr Khan was the lead clinical research fellow in novel cell therapy clinical trials, collaborating with leading oncologists and researchers on multiple research projects.

Dr Khan maintains an active interest in clinical trials, medical education and research, with previous experience as sub-investigator of various clinical trials including autologous tumour-infiltrating lymphocyte and NAR-T cell therapies. He has published several articles and abstracts in peer-reviewed journals and presented at state and national meetings.

Dr Khan is a fellow of the Royal Australasian College of Physicians (FRACP) and a member of several leading Australian and New Zealand cancer trial groups. He has expertise in immunotherapy treatments and novel immunotherapy agents. His clinical experience covers a broad range of solid tumour malignancies with special interest in thoracic cancers, genitourinary cancers, gastrointestinal cancers and melanoma.

Affiliations & Memberships

  • American Society of Clinical Oncology (ASCO)
  • Australasian Lung Cancer Trials Group (ALTG)
  • Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
  • Australia New Zealand Gynaecological Oncology Group (ANZGOG)
  • Medical Oncology Group of Australia (MOGA)
  • Private Cancer Physicians of Australia (PCPA)
  • Royal Australasian College of Physicians (RACP)
  • WA Clinical Oncology Group (WACOG)

Special Interests

Dr Yasir Khan accepts referrals for all cancer types, with a special clinical interest in:
  • Clinical research
  • Gastrointestinal cancer
  • Genitourinary cancer
  • Lung cancer
  • Melanoma

Icon Locations

Rockingham View centre

Publications

  • Individualising Systemic Therapies in First Line Treatment and beyond for Advanced Renal Cell Carcinoma. Y. Khan, T.D. Slattery & L.M. Pickering. Cancers, 2020; 12: 3750.

  • Treatment and outcomes for synovial sarcoma patients in Western Australia: the role of neoadjuvant chemoradiotherapy. Y. Khan, R. Carey-Smith, M. Taylor, J. Woodhouse, A. Jacques, D. Wood & A. Long. Cancer Reports, 2020; e1268.

  • Characterisation of the immune profile of oral tongue squamous cell carcinomas with advancing disease. K. Meehan, C. Leslie, M. Lucas. A. Jacques, D. Mirzai, J. Lim, Y. Khan, N. Wong, B. Solomon, C. Sader, P. Friedland, A. Mir. T. Semple & A.M. Lim. Cancer Medicine, 2020; 9(13): 4791-4807.

  • Eosinophilia and Neutrophilia Associated with Anti- PD-1 use in Metastatic Non-Small Cell Lung Cancer – A Case Report. Y. Khan & C. Lomma. Advances in Cancer Research & Clinical Imaging, 2021; 3(1).

  • 1106P International experience of ipilimumab and nivolumab in patients with advanced melanoma. P. Serra-Bellver, J.M. Versluis, H.K. Oberoi, T.D. Slattery, Y. Khan, J.R. Patrinelly. I. Pires da Silva, C. Martinez-Vila, N. Cook, D.M. Graham, C. Zhou, A. Gupta, A.M. Arance Fernandez, D.B. Johnson, G.V. Long, L. Pickering, J. Larkin, C.U. Blank & Lorigan. Annals of Oncology, 2020; 31(4): 747-748.

View all

Search